Is There a Better Therapeutic Time Window from Diagnosis to Treatment for Elderly Acute Myeloid Leukemia Patients Receiving Hypomethylating Agents?
Mediterr J Hematol Infect Dis
.
2024 Jul 1;16(1):e2024055.
doi: 10.4084/MJHID.2024.055.
eCollection 2024.
Authors
Matteo Molica
1
,
Luca Maurillo
2
,
Marco Rossi
1
,
Massimo Breccia
3
,
Carla Mazzone
4
,
Paolo de Fabritiis
2
4
,
Salvatore Perrone
5
Affiliations
1
Department of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, 88100 Catanzaro, Italy.
2
Department of Biomedicina e Prevenzione, Tor Vergata University, 00133 Rome, Italy.
3
Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, 00185 Rome, Italy.
4
Hematology, St. Eugenio Hospital, ASL Roma2, 00144 Rome, Italy.
5
Department of Hematology, Polo Universitario Pontino, S.M. Goretti Hospital, 04100 Latina, Italy.
PMID:
38984101
PMCID:
PMC11232675
DOI:
10.4084/MJHID.2024.055
No abstract available
Keywords:
Acute myeloid leukemia; Elderly patients; Hypomethylating agents.